World Patient Safety Summit Aims to Reduce Unnecessary C-Sections
Two survivors of C-section delivery and postpartum complications will be part of a distinguished panel at the upcoming 2018 World Patient Safety Science & Technology Summit in London, on Saturday, February 24.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180213006342/en/
Kristen Terlizzi will share her near-fatal experience of postpartum care at the 6th Annual World Patient Safety, Science & Technology Summit in London, UK. (Photo: Business Wire)
According to researchers, C-sections or deliveries of newborns by caesarean section, is on the rise but nearly half of those cases are unnecessary and complications from the procedure are not well known or understood. The Patient Safety Movement Foundation is pleased to announce the panelists participating in the upcoming Reducing Unnecessary C-Sections in Hospitals Panel. These include Jill Arnold and Kristen Terlizzi who have become fierce patient advocates since their near fatal experiences in delivering their infants by C-section and the complications that followed.
The Statistics: Internationally, C-sections are on the rise ranging from an average of 40.5% in Latin America/Caribbean area to 7.3% in Africa (Betran 2016). In the United States, one-third of patients give birth surgically (Martin, 2017) and international experts have identified this high cesarean rate as a significant maternal health safety issue (Council on Patient Safety in Women’s Health Care 2016).
Kristen Terlizzi’s post-partum medical care was so extreme, it inspired a scientific journal case study. An earlier C-section left her with a condition called Placenta Accreta – where placental tissue remains and spreads affecting other organs. Hemorrhaging during corrective surgery was so acute, she had her entire blood supply replaced.
Jill Arnold was the picture of health and breezed through a low-risk pregnancy and delivery but the lack of emphasis on postpartum care in the U.S. left her at risk. She began showing symptoms of DVT – Deep Vein Thrombosis – which could have easily killed her. “A leg-length clot had developed in a superficial vein that extended from my ankle all the way up to the groin,” said Arnold.
Unnecessary C-sections also pose long-term health risks including subsequent uterine scar rupture, abnormal placentation, increased risk of hemorrhage, and hysterectomy (Bauserman 2015, Marshall 2011, Rageth 1999, Galyean 2009) where there is an exponential increase in such complications with the number of prior cesareans (Clark 1985).
The Reducing Unnecessary C-sections panel will discuss best practices from around the world and announce the new Actionable Patient Safety Solutions related to this topic.
Members of the Global Panel include:
- Moderator: David C. Lagrew Jr., MD, Executive Medical Director of Women’s Service, St. Joseph-Hoag Health Region of Providence Healthcare – Dr. Lagrew is a maternal fetal medicine specialist and physician informaticist with a special interest in maternal quality improvement. He has helped develop and pioneer techniques in cesarean section reduction, emergent cesarean section drills, and maternal quality improvement in techniques.
- Kristen Terlizzi, Co-founder, National Accreta Foundation – Ms. Terlizzi now shares her patient story to educate audiences on abnormal placentation and the downstream costs of cesarean deliveries. Her medical case report is published in the official journal of the American Congress of Obstetricians and Gynecologists (ACOG) and her patient story has been featured in Vox Media, the Wall Street Journal and People.com.
- Jill Arnold, Co-founder, National Accreta Foundation - Jill Arnold’s research on C-section, VBAC and other delivery method data led to the creation of a registry of national hospital-level data that Consumer Reports licensed in 2013. Jill currently serves as the Vice Chair of the Arkansas Healthcare Transparency Initiative Task Force Board, is an Editorial Board Member of the Institute for Perinatal Quality Improvement and an Expert Consultant to the Delivery Decisions Initiative at Harvard’s Ariadne Labs as well as serving as a member of the steering committee of the California Maternal Quality Care Collaborative (CMQCC) Maternal Data Center since 2013.
- Siddarth Satish, Founder, Chief Executive Officer, Gauss Surgical - Siddarth Satish is the Founder and CEO of Gauss Surgical, a medical technology company using computer vision and machine learning to make surgery and childbirth safer and more cost-effective. He serves on the Technology Committee of the Anesthesia Patient Safety Foundation, and was named to the Forbes 30 Under 30 list in healthcare.
- Robert M. Silver, MD, Professor of Obstetrics and Gynecology, University of Utah Health Sciences Center – Dr. Silver joined the University of Utah Maternal-Fetal Medicine Division after completing his fellowship there in 1994. He is serving as the Chief of the Division of Maternal-Fetal Medicine and as Co-Director of Labor and Delivery at the UUHSC.
For more information, please visit the Patient Safety Movement Foundation website. Members of the media may request a press pass by visiting http://bit.ly/2mCeyay or by contacting Tanya Lyon – phone (949) 351-2858 or email email@example.com.
About Patient Safety Movement Foundation:
More than 200,000 U.S. patients and three million worldwide die each year from preventable causes. The Patient Safety Movement Foundation (PSMF) was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare to reduce that number of preventable deaths to zero by 2020 (0X2020). Improving patient safety requires a collaborative effort from all stakeholders, including patients, healthcare providers, medical technology companies, government, employers, and private payers. The PSMF works with all stakeholders to address problems with actionable solutions. The Foundation also convenes the World Patient Safety, Science and Technology Summit bringing together some of the world’s best minds for thought-provoking discussions and new ideas that challenge the status quo. By presenting specific, high-impact solutions to meet patient safety challenges, called Actionable Patient Safety Solutions, encouraging medical technology companies to share the data their products are purchased for, and asking hospitals to make commitments to implement Actionable Patient Safety Solutions, the Patient Safety Movement Foundation is working toward zero preventable deaths by 2020. Visit http://patientsafetymovement.org/.
Patient Safety Movement Foundation
Tanya Lyon, (949) 351-2858
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
ABB Showcases World-Leading e-Vehicle Fast Chargers and Launches AI Readiness Index at Hannover22.4.2018 10:00 | Pressemelding
ABB spotlighted its world-leading Terra HP family of fast chargers for electric vehicles at Hannover Messe, the biggest global industrial trade fair. By operating at powers of up to 350 kilowatts and adding as much as 300 kilometers of range to an electric vehicle in just 12 minutes, the Terra HP family of chargers have made electric cars more appealing for consumers by enabling them to refresh the batteries in about the same time required for filling up a petrol-powered car. Terra HP chargers are being installed around the world, and they have been selected for use by Electrify America, the biggest electric vehicle infrastructure project to date in the United States. ABB, whose broad array of digitally driven technologies for electric-power management are used by utilities and businesses worldwide, is also a global leader in industrial automation and robots enabled by artificial intelligence (AI). Demonstrating its commitment to helping the international community address the opportun
PSE: APM Forum 2018 Focus on Digitalisation for the Process Industries20.4.2018 15:13 | Pressemelding
At the 2018 Advanced Process Modelling (APM) Forum this week, process industry organisations presented on digital design and operations applications ranging from accelerating development of the next generation of pharmaceuticals to realising millions of dollars per year in increased profit for large process plants. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180420005517/en/ Ben Weinstein, head of R&D Product and Process Systems Modeling at Procter & Gamble, delivers the keynote speech on how digital design techniques are used systematically to accelerate innovation in P&G. (Photo: Business Wire) Introducing the conference, Prof. Costas Pantelides, MD of conference host Process Systems Enterprise (PSE), described the current wave of digitalisation as the culmination of many years of advanced modelling and IT development. “This is a time of extraordinary opportunities for the process industries” he said. Keynote speaker Ma
Aperta Provides Electronic Funds Transfer (EFT) in Cayman Islands20.4.2018 14:01 | Pressemelding
Once again, the Aperta Active Clearing System (ACS) has delivered the mechanism for a country to implement a world-class electronic payment processing environment to maximize a national payments system’s efficiency, effectiveness, security and control. Aperta partnered with the Cayman Islands ACH Operator (Prism Services (Cayman) Ltd.) and local commercial banks to deliver a new Electronic Funds Transfer system. The old process of banks swapping files in a wide-variety of standards and settling bilaterally has been replaced with a common system and standards, employing international-standard secure file transfer protocol, allowing participants to monitor real time net settlement and collateral positions via a secure portal. The Cayman Islands Automated Clearinghouse (CIACH) links all six of the country’s banks and provides the central clearing and settlement mechanism for banks to exchange direct debit and direct credit transactions seamlessly across the country. It is functionally NAC
FII Tech Growth Invests in SECO20.4.2018 13:39 | Pressemelding
FII Tech Growth, a fund managed by Fondo Italiano d’Investimento SGR, announces today its second investment in SECO SpA, one of the European leaders in the embedded electronics market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180420005413/en/ (Photo: SECO) SECO, headquartered in Arezzo, Tuscany, with subsidiaries in the U.S.A., Germany and Taiwan, was founded in 1979 by entrepreneurs Daniele Conti and Luciano Secciani. The company designs and manufactures micro-computers and integrated systems for industrial applications. With more than 250 employees, SECO supports customers with a worldwide presence such as Cimbali, Esaote, Technogym and Vimar, and generated revenue in excess of Euro 50 million in 2017. The ability to offer innovative solutions by using cutting-edge technologies has allowed SECO to grow steadily over time. The company developed a network of collaborations with universities and research centres La Sapi
Schlumberger Announces First-Quarter 2018 Results20.4.2018 11:05 | Pressemelding
Schlumberger Limited (NYSE:SLB) today reported results for the first quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Mar. 31, 2018 Dec. 31, 2017 Mar. 31, 2017 Sequential Year-on-year Revenue $7,829 $8,179 $6,894 -4% 14% Pretax operating income $974 $1,155 $757 -16% 29% Pretax operating margin 12.4% 14.1% 11.0% -169 bps 145 bps Net income (loss) - GAAP basis $525 $(2,255) $279 n/m 88% Net income, excluding charges & credits* $525 $668 $347 -21% 51% Diluted EPS (loss per share) - GAAP basis $0.38 $(1.63) $0.20 n/m 90% Diluted EPS, excluding charges & credits* $0.38 $0.48 $0.25 -21% 52% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. n/m = not meaningful Schlumberger Chairman and CEO Paal Kibsgaard commented, “As forecast, our results in the first quarter of 2018 largely reflected transitory factors, with seasonal reductions in activity in the Northern Hemisphere and planned project startup costs
Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases20.4.2018 10:30 | Pressemelding
Biogen (Nasdaq: BIIB) and Ionis Pharmaceuticals (Nasdaq: IONS) announced today they have expanded their strategic collaboration through a new ten-year collaboration agreement to develop novel antisense drug candidates for a broad range of neurological diseases. This collaboration capitalizes on Biogen’s expertise in neuroscience research and drug development and Ionis’ leadership in RNA targeted therapies with the goal of developing a broad pipeline of investigational therapies. It builds upon a productive collaboration that produced SPINRAZA, the first and only approved treatment for patients with spinal muscular atrophy. Today, April 20, 2018, Biogen and Ionis will host company conference calls and webcasts to discuss the new collaboration. Full webcast details can be found below. Under the terms of the collaboration, Biogen will pay Ionis $1 billion in cash, which will include $625 million to purchase 11,501,153 shares of Ionis common stock at a price of $54.34 per share, at an appr